top of page
Browse by category
Search


GLP-1ra receptor agonists role in the management of obesity in Australia
As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the...


GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...


Transcranial magnetic stimulation combined with cognitive training curbs impulsive eating
Scientists at the Mind, Brain, and Behavior Research Center at the University of Granada (CIMCYC, UGR), Spain, have revealed how - when...


Brain nerve cells control the beneficial effects of semaglutide
Researchers at the Sahlgrenska Academy at the University of Gothenburg have shown that it is possible to distinguish the nerve cells in...


GLORY-1 outcomes shows positive results for mazdutide - a dual glucagon GCG-1/GLP-1 receptor agonist
The results from GLORY-1 - a Phase 3 clinical study of mazdutide - a dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor...


Download Bariatric News issue 55
Issue 55 of Bariatric News is now available to read and/or download. In this issue, we report on the latest outcomes from the...


Journal Watch 21/5/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Egyptian survey reveals trends in bariatric surgery practices
A survey of Egyptian metabolic and bariatric surgeons (MBS) has revealed that procedural volumes are increasing, although economic...


Australian bariatric surgery under threat due to soaring insurance costs
An alarming number of Australian bariatric surgeons are considering shutting their clinics because of skyrocketing insurance costs and...


Novo Nordisk and Septerna to develop oral small molecule medicines for obesity
Novo Nordisk and Septerna have announced an exclusive global collaboration and license agreement to discover, develop and commercialise...
Browse by tag






bottom of page

